Date:4/29/2009

662 451 Depreciation and amortization - consolidated entities 27,313 17,687 Depreciation and amortization - allocable to noncontrolling interest of consolidated joint ventures (20) (8) ---------- ---------- Funds from operations available to common shares and partnership and LTIP units $47,701 $31,050 ========== ========== Funds from operations per share - diluted $0.56 $0.45 ========== ========== Weighted-average common shares and partnership and LTIP units outstanding - diluted 84,499,365 69,024,935 ========== ==========

Financial information for the current and, where applicable, the prior period has been presented to reflect the application of the following new accounting guidance adopted by the company effective January 1, 2009: FASB Staff Position APB 14-1 "Accounting for Convertible Debt That May be Settled Upon Conversion (Including Partial Cash Settlement)"; Statement of Financial Accounting Standard No. 160 "Noncontrolling Interests in Consolidated Financial Statements - An Amendment of ARB No. 51"; and FASB Staff Position EITF 03-6-1 "Determining Whether Instruments Granted in Share Based Payment Transactions are Participating Securities."

We present funds from operations, or FFO, available to common shares and partnership and LTIP units because we consider it an important supplemental measure of our operating performance and believe it is frequently used by securities analysts, investors and other interested parties in the evaluation of REITs, man
'/>"/>

SOURCE BioMed Realty Trust, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related medicine news :

1. Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison
2. Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
3. Four legendary LA BioMed physician-researchers honored
4. Sickle cell treatment developed at LA BioMed approved for phase 3 clinical trial
5. Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter
6. BioMedical Technology Solutions, Inc. a Division of BioMedical Technology Solutions Holdings, Inc. Symbol (BMTL) OTCBB Receives Frost & Sullivans Product Innovation of the Year Award
7. Foundation for Biomedical Research Announces Michael E. DeBakey Journalism Awards
8. Response Biomedical Corporation Reports 2008 Financial Results
9. Advance Internet Launches HireBioMedical.com
10. Hollow gold nanospheres show promise for biomedical and other applications
11. Foundation for Biomedical Research Releases Groundbreaking PSA